Danish biotech company Gubra launched a new business unit called Gubra Ventures on February 10, 2026, focused on creating independent biotechnology companies. 1 3 4 Zoë Johnson has been appointed as director to lead Gubra Ventures. 1 3 4 5 This launch supports Gubra's transformation from a preclinical CRO to a dual-business model emphasizing discovery partnerships and proprietary assets like UCN2 for obesity. 2 Sources: 1. https://medwatch.com/News/Pharma _ Biotech/article19003660.ece 2. https://www.ainvest.com/news/gubra-investor-biotech-transformation-2601/ 3. https://www.marketscreener.com/news/gubra-launches-gubra-ventures-ce7e5adfdd80f623 4. https://www.gubra.dk/mfn_news/gubra-launches-gubra-ventures-and-appoints-zoe-johnson-to-lead-new-venture-creation-unit/ 5. https://www.tradingview.com/news/modular_finance:2562a34429ef3:0-gubra-launches-gubra-ventures-and-appoints-zo-johnson-to-lead-new-venture-creation-unit/
- Get link
- X
- Other Apps